Agilon Health, Inc. — Form 8-K Summary
Business context and reporting period
Agilon Health, Inc. filed a current report on September 30, 2022 under Item 5.02 regarding a change in executive leadership. The filing does not report quarterly or annual financial results.
Executive appointment and compensation
- Priscilla Kasenchak was appointed Chief Accounting Officer effective September 30, 2022.
- Ms. Kasenchak previously served as Chief Accounting Officer of Edgewell Personal Care Company, The Bountiful Company, and The Hain Celestial Group.
- Her compensation includes a $25,000 sign-on bonus, $370,000 annual base salary, and an annual target bonus equal to 50% of base salary.
- She will also receive stock options valued at $80,000 under the Black-Scholes model and restricted stock units valued at $80,000 on the grant date. Both equity awards vest subject to continued employment through the applicable vesting dates.
Financial metrics and material changes
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating metrics, or guidance. It does not present comparable-period results or other material changes to the company’s financial performance.
Other disclosures, risks, and contingencies
- Ms. Kasenchak has no reportable family relationships with any director or executive officer.
- The filing states that there was no arrangement or understanding with another person regarding her selection as an officer.
- The filing reports no related-party transactions involving Ms. Kasenchak requiring disclosure under Item 404(a) of Regulation S-K.
- No specific risks, contingencies, unusual operating items, or management outlook are disclosed.
Key facts for investors to verify
- Effective date and scope of Ms. Kasenchak’s Chief Accounting Officer appointment.
- Cash compensation and equity award values, including applicable vesting conditions.
- Future filings for any additional compensation terms, executive transition details, or financial results.